COMMUNIQUÉS West-GlobeNewswire

NANOBIOTIX : La FDA donne son accord pour le lancement du premier essai d'Immuno Oncologie de Nanobiotix

26/12/2017 - 08:16

LA FDA DONNE SON ACCORD POUR LE LANCEMENT DU PREMIER ESSAI D'IMMUNO ONCOLOGIE DE NANOBIOTIX : UNE PHASE I/II AVEC NBTXR3 ACTIVE PAR RADIOTHERAPIE (SABR), CHEZ DES PATIENTS ATTEINTS DE CANCER DU POUMON NON A PETITES [...]

Summit Obtains Innovative Antibiotic Discovery and Development Platform Through Acquisition of Discuva Ltd.

23/12/2017 - 22:02

Summit Therapeutics plc ('Summit' or the 'Company') SUMMIT OBTAINS INNOVATIVE ANTIBIOTIC DISCOVERY AND DEVELOPMENT PLATFORM THROUGH ACQUISITION OF DISCUVA LTD Positions Summit as a Leader in Research & Development [...]

Summit Obtains Innovative Antibiotic Discovery and Development Platform Through Acquisition of Discuva Ltd

23/12/2017 - 22:00

Positions Summit as a Leader in Research & Development of New Classes of Antibiotics Enhances Summit’s Broader Business in Rare and Infectious Diseases Supports Mission to Discover and Develop Therapies for Patients [...]

MedMira Reports First Quarter Results

23/12/2017 - 01:00

HALIFAX, Nova Scotia, Dec. 22, 2017 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSX-V: MIR ), reported today on its financial results for the quarter ended October 31, 2017. Profit and Loss Highlights Revenue: In Q1 [...]

Helius Medical Technologies Announces Closing of First Tranche of Private Placement

23/12/2017 - 00:54

NEWTOWN, Pa., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX: HSM ) (TSX:HSM.WT) (OTCQB:HSDT) (“Helius” or the “Company”) , a medical technology company focused on neurological wellness, is [...]

MolecularMD obtains FDA Authorization for the MRDx® BCR-ABL Test as a Companion Diagnostic for Treatment-Free Remission in Ph+ CML-CP Patients Treated with Tasigna

23/12/2017 - 00:02

PORTLAND, Ore. and CAMBRIDGE, Mass., Dec. 22, 2017 (GLOBE NEWSWIRE) -- MolecularMD Corporation, a diagnostics company that enables the development and commercialization of precision medicines in oncology, announced [...]

Kalytera Announces Approval of Shares for Services and Settlement of Debt Transaction with The Salzman Group of Israel

22/12/2017 - 23:29

SAN FRANCISCO and TEL AVIV, Israel, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the " Company " or " Kalytera ") today announced that the TSX Venture Exchange (“ TSXV [...]

Portola Pharmaceuticals Provides Update on Biologics License Application (BLA) for AndexXa® (andexanet alfa)

22/12/2017 - 23:23

SOUTH SAN FRANCISCO, Calif., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA ) today announced that the U.S. Food and Drug Administration (FDA) will extend its review of the Biologics [...]

MPX Closes Oversubscribed Private Placement Offering of $26.5 Million

22/12/2017 - 23:02

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Dec. 22, 2017 (GLOBE NEWSWIRE) -- (CSE:MPX) (OTC:MPXEF) MPX Bioceutical Corporation (the “ Company ” or “ MPX ”) (CSE: [...]

Novartis drug Tasigna® is approved by FDA as first and only CML therapy with Treatment-free Remission data in its label

22/12/2017 - 22:43

Inclusion of Treatment-free Remission (TFR) data provides additional and novel option in management of Ph+ CML-CP Deep and sustained molecular response included as key eligibility criteria for attempting TFR after [...]

Aeterna Zentaris Provides Update on Litigation against David Dodd and Philip Theodore

22/12/2017 - 22:15

CHARLESTON, S.C., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (the “Company” or “Aeterna Zentaris”) (NASDAQ: AEZS ) (TSX: AEZS ), a specialty biopharmaceutical company engaged in developing and [...]

ATW Tech Completes a Private Placement of Units of $423,640

22/12/2017 - 22:00

MONTREAL, Dec. 22, 2017 (GLOBE NEWSWIRE) -- AtmanCo inc. (“AtmanCo” or the “Company”) (TSX-V: ATW ) is pleased to announce the closing of a private placement consisting of the issuance of 3 530 333 units at a price of $ [...]

ATW Tech complète un placement privé d’unités de 423 640 $

22/12/2017 - 22:00

MONTRÉAL, 22 déc. 2017 (GLOBE NEWSWIRE) -- ATW Tech (« AtmanCo Inc. » ou la « Société ») (TSX CROISSANCE:ATW) annonce aujourd'hui la clôture d’un placement privé de 423 640 $ par l’émission de 3 530 333 unités au prix [...]

Abattis Provides Company Update and Comments on LOI Regarding Green Tree Therapeutics

22/12/2017 - 21:26

VANCOUVER, British Columbia, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the " Company " or " Abattis ") (CSE:ATT) (OTC:ATTBF) is pleased to provide a company update and further commentary on its [...]

PSI Raises Record Amount for Charity at its 20th Annual Golf Tournament

22/12/2017 - 20:45

ARLINGTON, Va., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Planned Systems International, Inc. (PSI), a leading provider of Health IT solutions to the federal government, is pleased to announce that it raised a record for [...]

NEOVACS : AVIS AUX PORTEURS DE BSA NEOVACS 2017 (FR0013275971) MODALITES D'AJUSTEMENT LEGAL ET CONTRACTUEL

22/12/2017 - 19:14

AVIS AUX PORTEURS DE BSA NEOVACS 2017 (FR0013275971) MODALITES D'AJUSTEMENT LEGAL ET CONTRACTUEL Paris, le 22 décembre 2017 -19h00 CET -NEOVACS (Euronext Growth Paris : ALNEV) fait savoir que les bons de souscription [...]

Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program

22/12/2017 - 18:17

Company Release no. 25/2017 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 22 December 2017 Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program Today, the Board of Directors of Veloxis [...]

Catalyst Biosciences Announces Closing of Public Offering of Common Stock

22/12/2017 - 18:15

SOUTH SAN FRANCISCO, Calif., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO ), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]

Cannabis Wheaton Income Corp. Announces Signing of Definitive Agreement With Streaming Partner CannTx Life Sciences Inc.

22/12/2017 - 18:00

VANCOUVER, British Columbia, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX-V: CBW ) (" Wheaton Income " or the " Company ") is pleased to announce that further to its [...]